A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions

Authors:

Abstract
We show for the first time that PD-1 is palmitoylated, identify DHHC9 as the predominant enzyme for its palmitoylation, and reveal the molecular mechanisms underlying its effects on PD-1 stability and functions. Importantly, we also designed PD1-PALM, a competitive inhibitor of PD-1 palmitoylation, and this first-in-class molecule may inspire the development of new checkpoint inhibitors.
Funding Information
  • National Natural Science Foundation of China (82030104)
  • National Natural Science Foundation of China (81874050)
  • National Natural Science Foundation of China (81572326)
  • National Natural Science Foundation of China (81322036)
  • National Natural Science Foundation of China (81421001)
  • National Natural Science Foundation of China (81702969)
  • National Natural Science Foundation of China (81530072)
  • National Natural Science Foundation of China (81830081)
  • National Natural Science Foundation of China (31871009)
  • National Natural Science Foundation of China (81772506)
  • National Natural Science Foundation of China (21335002)
  • National Key Research and Development Program of China (2016YFC0906000)
  • National Key Research and Development Program of China (2016YFC0906002)
  • Scientific and Innovative Action Plan of Shanghai (20JC1410700)
  • Natural Science Foundation of Shanghai Municipality (18ZR1402800)
  • Fudan University (JIH1340050)

This publication has 26 references indexed in Scilit: